A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
复制标题
新型五长链非编码RNA特征组可改善胆管癌患者的高风险生存预测
DOI:
10.18632/aging.202446
复制
发表时间:
2021-01-20
期刊:
影响因子:
--
通讯作者:
Chen G
中科院分区:
文献类型:
--
作者:
Xie X;Wang Y;Zhang S;Li J;Yu Z;Ding X;Ye L;Gong P;Zhu Q;Li J;Chen Z;Yao X;Du Z;Zeng Q;Chen H;Yang Z;Chen G
Cholangiocarcinoma (CCA) is a fatal disease with dismal survival rates. Long non-coding RNA (lncRNA) expression profiling as potential prognostic biomarkers play critical roles in tumor initiation, development, and poor prognosis. Identifying specific lncRNA to predict the prognosis of CCA patients in the early stages is very important for improving a patient’s survival. In the current study, we aimed to establish a novel risk-stratification lncRNA signature panel in CCA. The initial lncRNA discovery was identified in The Cancer Genome Atlas database (TCGA cohort). The Cox regression analysis was used to establish the lncRNA prognostic model and the receiver operating characteristic (ROC) curve analysis was performed to assess the specificity and sensitivity of the model. This was followed by independent validation of the lncRNA signature in the CCA patients from the First Affiliated Hospital of Wenzhou Medical University (WMU cohort). Furthermore, by using the Gene Ontology function and Kyoto Encyclopedia Gene and Genome pathway enrichment analysis, we explored the potential function of prognosis lncRNA. Finally, five lncRNA (HULC; AL359715.5; AC006504.8; AC090114.2; AP00943.4) were screened to establish the predictive model that significantly associated with poor overall survival(HR:4.879;95%CI,1.587-14.996;p=0.006). This five-lncRNA signature model showed excellent accuracy in the TCGA cohort (AUC=0.938), and also robustly predicted survival in the validation WMU cohort(AUC=0.816). Functional enrichment analysis suggested prognostic lncRNA was primarily associated with CCA-related biological processes. Our data established a novel lncRNA signature model for CCA risk-stratification and robust identification of CCA patients with poor molecular genotypes. Moreover, it revealed new molecular mechanisms of CCA.
登录
查看更多内容
影响因子:
7
作者:
Harrow J;Frankish A;Gonzalez JM;Tapanari E;Diekhans M;Kokocinski F;Aken BL;Barrell D;Zadissa A;Searle S;Barnes I;Bignell A;Boychenko V;Hunt T;Kay M;Mukherjee G;Rajan J;Despacio-Reyes G;Saunders G;Steward C;Harte R;Lin M;Howald C;Tanzer A;Derrien T;Chrast J;Walters N;Balasubramanian S;Pei B;Tress M;Rodriguez JM;Ezkurdia I;van Baren J;Brent M;Haussler D;Kellis M;Valencia A;Reymond A;Gerstein M;Guigó R;Hubbard TJ
通讯作者:
Hubbard TJ
影响因子:
--
作者:
Lu, Xu;Zhou, Chuang;Zhai, Wenlong
通讯作者:
Zhai, Wenlong
影响因子:
2.3
作者:
Guro, Hanisah;Kim, Jin Won;Han, Ho-Seong
通讯作者:
Han, Ho-Seong
影响因子:
15.9
作者:
Samudio, Ismael;Harmancey, Romain;Andreeff, Michael
通讯作者:
Andreeff, Michael
影响因子:
29.4
作者:
Sia, Daniela;Villanueva, Augusto;Llovet, Josep M.
通讯作者:
Llovet, Josep M.